Literature DB >> 21879883

Risk factors for nonadherence with Pap testing in HIV-infected women.

Amy S Baranoski1, C Robert Horsburgh, L Adrienne Cupples, Ann Aschengrau, Elizabeth A Stier.   

Abstract

BACKGROUND: HIV-infected women are at increased risk for cervical cancer; thus, adherence with Papanicolaou (Pap) testing is of particular importance. The objective of this study was to identify risk factors for inadequate Pap testing in a diverse cohort of HIV-infected women at a large urban safety net HIV clinic.
METHODS: This retrospective cohort study assessed HIV-infected women aged 18?60 years in care between October 1, 2003, and March 31, 2008, for risk factors for inadequate Pap testing. Unadjusted odds ratios (OR) with confidence intervals (CI) and multivariate analyses with generalized estimating equations for correlated data were calculated.
RESULTS: Of 549 women, 293 (53.4%) had a Pap test during each follow-up period. Women who were older, white or Hispanic race/ethnicity, U.S. born, unemployed, drug users, and those with advanced HIV had increased odds of no Pap testing in unadjusted analyses. In multivariate analyses, U.S.-born women who were white or unemployed or had a baseline CD4 count <200 cells/mm(3) had increased odds of no Pap testing (OR 2.0, 95% CI 1.3-3.1; OR 2.3, CI 1.0-5.0; OR 1.7, CI 1.0-2.9, respectively). For non-U.S.-born women, age ?50 years (OR 3.9, CI 1.7-9.0), non-English-speaking status (OR 1.6, CI 1.0-2.4), and drug use (OR 5.8, CI 2.5-13.9) were associated with no Pap testing.
CONCLUSIONS: U.S.-born status and low CD4 count were associated with increased odds of inadequate Pap testing. Further study is needed to identify interventions to improve Pap testing adherence in this high-risk group.

Entities:  

Mesh:

Year:  2011        PMID: 21879883      PMCID: PMC3216072          DOI: 10.1089/jwh.2010.2465

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  34 in total

1.  Breast and cervical cancer screening: sociodemographic predictors among White, Black, and Hispanic women.

Authors:  Elizabeth Selvin; Kate M Brett
Journal:  Am J Public Health       Date:  2003-04       Impact factor: 9.308

2.  Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.

Authors:  Maria Hewitt; Susan S Devesa; Nancy Breen
Journal:  Prev Med       Date:  2004-08       Impact factor: 4.018

3.  Individual-, neighborhood-, and state-level socioeconomic predictors of cervical carcinoma screening among U.S. black women: a multilevel analysis.

Authors:  Geetanjali D Datta; Graham A Colditz; Ichiro Kawachi; S V Subramanian; Julie R Palmer; Lynn Rosenberg
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

4.  Breast and cervical cancer screening among Appalachian women.

Authors:  H Irene Hall; Robert J Uhler; Steven S Coughlin; Daniel S Miller
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-01       Impact factor: 4.254

5.  Cervical screening in HIV-positive women: characteristics of those who default and attitudes towards screening.

Authors:  S Shah; H Montgomery; C Smith; S Madge; P Walker; H Evans; M Johnson; C Sabin
Journal:  HIV Med       Date:  2006-01       Impact factor: 3.180

6.  Cancer screening among Latino subgroups in the United States.

Authors:  Sherri Sheinfeld Gorin; Julia E Heck
Journal:  Prev Med       Date:  2005-05       Impact factor: 4.018

7.  Social and cultural barriers to Papanicolaou test screening in an urban population.

Authors:  Kian Behbakht; Anne Lynch; Stephanie Teal; Koen Degeest; Stewart Massad
Journal:  Obstet Gynecol       Date:  2004-12       Impact factor: 7.661

8.  Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study.

Authors:  T C Wright; T V Ellerbrock; M A Chiasson; N Van Devanter; X W Sun
Journal:  Obstet Gynecol       Date:  1994-10       Impact factor: 7.661

9.  Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women.

Authors:  C Six; I Heard; C Bergeron; G Orth; J D Poveda; P Zagury; P Cesbron; C Crenn-Hébert; R Pradinaud; M Sobesky; C Marty; M L Babut; J E Malkin; A Odier; S Fridmann; J P Aubert; J B Brunet; I de Vincenzi
Journal:  AIDS       Date:  1998-06-18       Impact factor: 4.177

10.  Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count.

Authors:  Felipe García; Elisa de Lazzari; Montserrat Plana; Pedro Castro; Gabriel Mestre; Meritxell Nomdedeu; Emilio Fumero; Esteban Martínez; Josep Mallolas; José L Blanco; José M Miró; Tomás Pumarola; Teresa Gallart; José M Gatell
Journal:  J Acquir Immune Defic Syndr       Date:  2004-06-01       Impact factor: 3.731

View more
  13 in total

1.  Factors associated with time to colposcopy after abnormal Pap testing in HIV-infected women.

Authors:  Amy S Baranoski; Elizabeth A Stier
Journal:  J Womens Health (Larchmt)       Date:  2011-12-05       Impact factor: 2.681

2.  Low Papanicolaou smear screening rate of women with HIV infection: a nationwide population-based study in Taiwan, 2000-2010.

Authors:  Yen-Chin Chen; Hsiao-Ying Liu; Chung-Yi Li; Nan-Yao Lee; Wen-Chien Ko; Cheng-Yang Chou; Tung-Han Hsieh; Nai-Ying Ko
Journal:  J Womens Health (Larchmt)       Date:  2013-08-30       Impact factor: 2.681

3.  Factors Associated with Adherence to Routine Screening Mammography in HIV-Infected Women.

Authors:  Zoe M Weinstein; Tracy A Battaglia; Amy S Baranoski
Journal:  J Womens Health (Larchmt)       Date:  2016-01-26       Impact factor: 2.681

4.  Perceptions of barriers and facilitators to cervical cancer screening among low-income, HIV-infected women from an integrated HIV clinic.

Authors:  Faith E Fletcher; Meredith Buchberg; Leslie R Schover; Karen Basen-Engquist; Mirjam-Colette Kempf; Roberto C Arduino; Damon J Vidrine
Journal:  AIDS Care       Date:  2014-03-18

5.  Number of Primary Care Visits Associated with Screening for Cervical Dysplasia among Women with HIV Infection in Harris County, Texas, United States of America.

Authors:  Natalie Jm Dailey Garnes; Gypsyamber D'Souza; Elizabeth Chiao
Journal:  HIV Adv Res Dev       Date:  2015-02-16

6.  Cervical cancer screening among HIV-infected women in an urban, United States safety-net healthcare system.

Authors:  Arti Barnes; Andrea C Betts; Eric K Borton; Joanne M Sanders; Sandi L Pruitt; Claudia Werner; Andres Bran; Carolee D Estelle; Bijal A Balasubramanian; Stephen J Inrig; Ethan A Halm; Celette Sugg Skinner; Jasmin A Tiro
Journal:  AIDS       Date:  2018-08-24       Impact factor: 4.177

7.  Cervical cancer screening adherence among HIV-positive female smokers from a comprehensive HIV clinic.

Authors:  Faith E Fletcher; Damon J Vidrine; Irene Tami-Maury; Heather E Danysh; Rachel Marks King; Meredith Buchberg; Roberto C Arduino; Ellen R Gritz
Journal:  AIDS Behav       Date:  2014-03

8.  Screening for Cervical Cancer and Sexually Transmitted Diseases Among HIV-Infected Women.

Authors:  Emma L Frazier; Madeline Y Sutton; Yunfeng Tie; A D McNaghten; Janet M Blair; Jacek Skarbinski
Journal:  J Womens Health (Larchmt)       Date:  2015-10-08       Impact factor: 2.681

9.  Improving cervical cancer screening rates in an urban HIV clinic.

Authors:  Sara L Cross; Sanaa H Suharwardy; Phani Bodavula; Kenneth Schechtman; E Turner Overton; Nur F Onen; Michael A Lane
Journal:  AIDS Care       Date:  2014-03-13

10.  Knowledge, awareness and attitudes about cervical cancer among women attending or not an HIV treatment center in Lao PDR.

Authors:  Chanvilay Sichanh; Fabrice Quet; Phetsavanh Chanthavilay; Joeffroy Diendere; Vatthanaphone Latthaphasavang; Christophe Longuet; Yves Buisson
Journal:  BMC Cancer       Date:  2014-03-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.